Cedar Pollen Allergy - Pipeline Review, H2 2015 Is Released Is Released Cedar Pollen Allergy - Pipeline Review, H2 2015 Summary Global Markets Direct s, Cedar Pollen Allergy Pipeline Review, H2 2015 , provides an overview of the Cedar Pollen Allergy s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy and special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Cedar Pollen Allergy - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Cedar Pollen Allergy and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Cedar Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Cedar Pollen Allergy pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Cedar Pollen Allergy - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Cedar Pollen Allergy pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and
1
expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=173388/cedar-pollenallergy-pipeline-review-h2-2015
Browse
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=173388/cedar-pollen-allergy-pipeline-review-h2-2015 Table of Contents
Introduction 5 Global Markets Direct Report Coverage 5 Cedar Pollen Allergy Overview 6 Therapeutics Development 7 Pipeline Products for Cedar Pollen Allergy - Overview 7 Pipeline Products for Cedar Pollen Allergy - Comparative Analysis 8 Cedar Pollen Allergy - Therapeutics under Development by Companies 9 Cedar Pollen Allergy - Therapeutics under Investigation by Universities/Institutes 10 Cedar Pollen Allergy - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Cedar Pollen Allergy - Products under Development by Companies 13 Cedar Pollen Allergy - Products under Investigation by Universities/Institutes 14 Cedar Pollen Allergy - Companies Involved in Therapeutics Development 15 Anergis SA 15 Biomay AG 16 Circassia Pharmaceuticals Plc 17 Immunomic Therapeutics, Inc. 18 Japan Tobacco Inc. 19 REGiMMUNE Corporation 20 2
Cedar Pollen Allergy - Therapeutics Assessment 21 Assessment by Monotherapy Products 21 Assessment by Target 22 Assessment by Route of Administration 23 Assessment by Molecule Type 25 Drug Profiles 27 AllerJ - Drug Profile 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 ASP-4070 - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Drugs for Cedar Pollen Allergy - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 japanese cedar hypoallergenic vaccine - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 JCC-LAMP-Vax - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 MC-LAMP-Vax - Drug Profile 33 3
Product Description 33 Mechanism of Action 33 R&D Progress 33 RGI-1001 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 TO-206 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Vaccine for Cedar Pollen Allergy - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Vaccine for Japanese Cedar Pollen Allergy - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Cedar Pollen Allergy - Recent Pipeline Updates 38 Cedar Pollen Allergy - Dormant Projects 40 Cedar Pollen Allergy - Product Development Milestones 41 Featured News & Press Releases 41 Mar 09, 2015: Immunomic Therapeutics to Present at BIO-Europe Annual Conference 41 Feb 20, 2015: Immunomic Therapeutics to Present Data on Its Proprietary LAMP Vaccine Platform at 2015 American Academy of Allergy, Asthma and Immunology Meeting 41
4
Apr 24, 2013: Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study To Treat Japanese Red Cedar Allergy 42 Nov 08, 2012: Immunomic Therapeutics Doses First Patient In Phase I Clinical Trial Of JRC-LAMP-Vax Vaccine To Treat Japanese Red Cedar Allergy 42 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 44 Disclaimer 45
Read More http://www.idatainsights.com/reports-landing-page.php?id=173388/cedar-pollenallergy-pipeline-review-h2-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects
5
6
7